Trials / Completed
CompletedNCT03611777
The OPTI Study in Spain Looks at the History Flare-ups in Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Inhaled Steroids.
Non-interventional, Cross-sectional, Multicenter Study to Describe the Exacerbations Profile of COPD Patients Treated With ICS in a Real-life Primary Care Population in Spain. OPTI Study.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 901 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
This non-Interventional, descriptive, cross-sectional cohort and multicentre study will be conducted with COPD patients attended at Spanish Primary Care offices.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Inhaled corticosteroid | Drug |
Timeline
- Start date
- 2018-08-14
- Primary completion
- 2020-01-31
- Completion
- 2020-01-31
- First posted
- 2018-08-02
- Last updated
- 2021-04-08
- Results posted
- 2021-02-17
Locations
169 sites across 1 country: Spain
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03611777. Inclusion in this directory is not an endorsement.